| Description | Albiglutide fragment (GLP-1 (7-36) analog) TFA represents a biologically active segment of Albiglutide, resistant to DPP-4 degradation due to its structure as a GLP-1 analog. It functions as a long-acting agonist of the GLP-1 receptor, derived from a fusion of a GLP-1 dimer with the human albumin gene. Clinically, this compound demonstrates a pronounced reduction in glycosylated hemoglobin (A1C) levels, rendering it a valuable therapeutic in type 2 diabetes (T2D) research [1] [2] [3] [4]. |
| Synonyms | GLP-1-Gly8 TFA, GLP-1 (7-36) analog TFA |
| molecular weight | N/A |
| Molecular formula | C148H224N40O45.xC2HF3O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |